Libtayo 350 mg/7 ml
Libtayo 350 mg/7 ml is a medicine authorised by Swissmedic under authorisation number 67094. The authorisation holder is Regeneron Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 May 2020 and the authorisation is limited until 04 October 2027. ATC code L01FF06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67094 |
|---|---|
| Name | Libtayo 350 mg/7 ml |
| Full name | Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Regeneron Switzerland GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF06 |
| First authorisation | 27 May 2020 |
| Authorisation validity | 04 October 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 27 May 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Durchstechflasche(n) | L01FF06 | 07.16.1. | A |
Scroll the table sideways
Frequently asked questions
Is Libtayo 350 mg/7 ml authorised in Switzerland?
Yes. Libtayo 350 mg/7 ml is authorised by Swissmedic under authorisation number 67094, data as of 01 September 2026. The authorisation is limited until 04 October 2027.
Which dispensing category does Libtayo 350 mg/7 ml have?
Libtayo 350 mg/7 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Libtayo 350 mg/7 ml?
The authorisation holder is Regeneron Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.